Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan injection), ...

Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...

The Bank Windhoek Cancer Apple Project has raised N$38.4 million since its inception in 2000.This significant milestone was announced at an event last week on Friday, where Bank Windhoek presented a ...

In the past, Dr. Horowitz had been a paid consultant for Purple Biotech.

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.

Restaurant critic and journalist Giles Coren has announced his diagnosis with prostate cancer. Writing in his column for The ...

While one in eight men are diagnosed with prostate cancer in their lifetime, the VA says for veterans, it's much higher.

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...